AHA-supported bill would improve access to opioid use disorder treatment
The AHA yesterday voiced support for the Opioid Treatment Access Act (H.R. 6279), bipartisan legislation that would take steps to facilitate patients’ access to methadone treatment for opioid use disorder. The bill would direct the Substance Abuse and Mental Health Services Administration to study the impact of certain flexibilities implemented during the COVID-19 public health emergency to enhance access to methadone treatment services and reduce stigma; allow patients to receive one-month supplies of methadone after two years of continuous treatment; permit pharmacies to dispense methadone; and codify regulations that allow opioid treatment programs to operate mobile medication components without separate registration.
Related News Articles
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The AHA Sept. 24 expressed support for the Medical Student Education Authorization Act (H.R. 5428), legislation introduced in the House Sept. 17 that would…
Headline
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a…
Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote that would have funded the government through Nov. 21. The CR was passed by…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…